 |
|
Lung Cancer Trial Results
11. Motexafin Gadolinium Slows Brain Damage from the Spread of Non-Small Cell Lung Cancer
(Posted: 06/04/2006) - The addition of the drug motexafin gadolinium to whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer significantly delayed the progression of neurological damage, according to findings presented at the 2006 meeting of the American Society of Clinical Oncology.
12. Elderly Benefit From Chemotherapy After Surgery for Early Non-Small Cell Lung Cancer
(Posted: 06/03/2006, Reviewed: 05/01/2007) - Elderly patients with early-stage non-small cell lung cancer who received chemotherapy following surgery lived longer than those who'd had surgery alone, without an increase in treatment-related toxicity or hospitalization, according to findings presented at the 2006 meeting of the American Society of Clinical Oncology.
13. Chest X-Rays Can Detect Early Lung Cancer But Also Can Produce Many False-Positive Results
(Posted: 12/20/2005) - A new study from the NCI shows that screening for lung cancer with chest X-rays can detect early lung cancer but can also produce many false-positive test results, causing needless extra tests. This report summarizes preliminary results from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
14. Peer Program Helps Childhood Cancer Survivors to Quit Smoking
(Posted: 09/13/2005) - A large randomized clinical trial found that a peer-counseling approach to smoking cessation doubled the quit rate among childhood cancer survivors compared to a self-help approach, and at a relatively low cost compared to other interventions known to be successful, according to the Sept. 20, 2005, issue of the Journal of Clinical Oncology.
15. Erlotinib (Tarceva®) Plus Chemotherapy Fails to Improve Overall Survival in Non-Small Cell Lung Cancer
(Posted: 08/29/2005) - Non-small cell lung cancer patients receiving standard chemotherapy plus the drug erlotinib (Tarceva®) did not live any longer than those on chemotherapy alone, according to a report in the Sept. 1, 2005, issue of the Journal of Clinical Oncology.
< Previous 1 2 3 4 5 6 Next >
|
|
|
